Pressure Ulcer Prevention in Intensive Care Unit (ICU)

This study has been completed.
Information provided by (Responsible Party):
Melbourne Health Identifier:
First received: May 17, 2011
Last updated: May 8, 2015
Last verified: May 2015

The study is designed as a randomised controlled trial of trauma patients admitted to the Royal Melbourne Hospital (RMH) Emergency Department (ED) and subsequently transferred to the Intensive Care Unit (ICU). Patients meeting the study inclusion criteria will be randomly allocated to either the control group that will receive usual pressure ulcer prevention strategies or the trial group that will receive usual care plus have a Mepilex Border Sacrum dressing applied to their sacrum and Mepilex Boarder Heel dressing applied to each heel in the ED.

Hypothesis:Patients treated with Mepilex Border dressings will have a lower incidence rate of sacral and heel pressure ulcer development than patients receiving standard care.

Condition Intervention
Pressure Ulcers
Device: Mepilex Border Dressing

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: A Prospective Randomised Controlled Trial of the Effectiveness of Absorbent Silicone Self Adherent Dressings in the Prevention of Sacral and Heel Pressure Ulcers in Trauma and Critically Ill ED/ICU Patients

Resource links provided by NLM:

Further study details as provided by Melbourne Health:

Primary Outcome Measures:
  • Pressure ulcer incidence [ Time Frame: Weekly ] [ Designated as safety issue: No ]
    Number of pressure ulcers developed in the ICU per week

Secondary Outcome Measures:
  • Cost [ Time Frame: Weekly ] [ Designated as safety issue: No ]
    The cost of treating developed pressure versus the cost of preventing the development of pressure ulcers

Enrollment: 440
Study Start Date: June 2011
Study Completion Date: June 2013
Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Intervention
Patients in this arm will have Mepilex dressings applied to their sacrum and heels
Device: Mepilex Border Dressing
Soft silicone self adherent dressing
Other Names:
  • Mepilex Border Sacrum
  • Mepilex Heel
No Intervention: Control
Patients in this arm will have standard care

  Show Detailed Description


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • ED and ICU admission for critical illness and/or major trauma Over 18 years old

Exclusion Criteria:

  • Less than 18 years old Suspected or actual spinal injury Pre-existing sacral or heel pressure ulcer Trauma to sacral and/or heel area
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01356459

Australia, Victoria
Royal Melbourne Hospital
Melbourne, Victoria, Australia, 3050
Sponsors and Collaborators
Melbourne Health
  More Information

No publications provided

Responsible Party: Melbourne Health Identifier: NCT01356459     History of Changes
Other Study ID Numbers: 2010.261
Study First Received: May 17, 2011
Last Updated: May 8, 2015
Health Authority: Australia: Human Research Ethics Committee

Keywords provided by Melbourne Health:
Pressure ulcers

Additional relevant MeSH terms:
Pressure Ulcer
Pathologic Processes
Skin Diseases
Skin Ulcer processed this record on October 06, 2015